353 related articles for article (PubMed ID: 30344249)
1. Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System.
Nath A; Haktanirlar G; Varga Á; Molnár MA; Albert K; Galambos I; Koris A; Vatai G
Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344249
[TBL] [Abstract][Full Text] [Related]
2. Probiotics in the gastrointestinal diseases of the elderly.
Malaguarnera G; Leggio F; Vacante M; Motta M; Giordano M; Bondi A; Basile F; Mastrojeni S; Mistretta A; Malaguarnera M; Toscano MA; Salmeri M
J Nutr Health Aging; 2012 Apr; 16(4):402-10. PubMed ID: 22499466
[TBL] [Abstract][Full Text] [Related]
3. Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide Utilization by Intestinal
Arnold JW; Simpson JB; Roach J; Bruno-Barcena JM; Azcarate-Peril MA
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30332787
[TBL] [Abstract][Full Text] [Related]
4. Prebiotics and Probiotics for Gastrointestinal Disorders.
Rau S; Gregg A; Yaceczko S; Limketkai B
Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542689
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel bioactive lactose-derived oligosaccharides by microbial glycoside hydrolases.
Díez-Municio M; Herrero M; Olano A; Moreno FJ
Microb Biotechnol; 2014 Jul; 7(4):315-31. PubMed ID: 24690139
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic use of symbiotics.
Flesch AG; Poziomyck AK; Damin DC
Arq Bras Cir Dig; 2014; 27(3):206-9. PubMed ID: 25184774
[TBL] [Abstract][Full Text] [Related]
7.
María Remes Troche J; Coss Adame E; Ángel Valdovinos Díaz M; Gómez Escudero O; Eugenia Icaza Chávez M; Antonio Chávez-Barrera J; Zárate Mondragón F; Antonio Ruíz Velarde Velasco J; Rafael Aceves Tavares G; Antonio Lira Pedrín M; Cerda Contreras E; Carmona Sánchez RI; Guerra López H; Solana Ortiz R
Therap Adv Gastroenterol; 2020; 13():1756284820971201. PubMed ID: 33281937
[TBL] [Abstract][Full Text] [Related]
8. Probiotic-fortified fruit juices: Health benefits, challenges, and future perspective.
Naseem Z; Mir SA; Wani SM; Rouf MA; Bashir I; Zehra A
Nutrition; 2023 Nov; 115():112154. PubMed ID: 37536023
[TBL] [Abstract][Full Text] [Related]
9. Postbiotics: A new member in the biotics family.
Toca MDC; Burgos F; Tabacco O; Vinderola G
Arch Argent Pediatr; 2023 Oct; ():e202310168. PubMed ID: 37824476
[TBL] [Abstract][Full Text] [Related]
10. Nutraceuticals and biotics in pediatric gastrointestinal disorders.
Corsello A; Scatigno L; Fiore G; Baresi S; Eletti F; Zuccotti G; Strisciuglio C; Dilillo D; Verduci E
Eur J Clin Nutr; 2024 Feb; 78(2):87-98. PubMed ID: 37875612
[TBL] [Abstract][Full Text] [Related]
11. World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics.
Guarner F; Sanders ME; Szajewska H; Cohen H; Eliakim R; Herrera-deGuise C; Karakan T; Merenstein D; Piscoya A; Ramakrishna B; Salminen S; Melberg J
J Clin Gastroenterol; 2024 Jul; 58(6):533-553. PubMed ID: 38885083
[No Abstract] [Full Text] [Related]
12. Production of lactulose from lactose using a novel cellobiose 2-epimerase from Clostridium disporicum.
Wang B; Lei S; Li Q; Luo Y
Enzyme Microb Technol; 2024 Jun; 179():110466. PubMed ID: 38889605
[TBL] [Abstract][Full Text] [Related]
13. Computational prediction of new therapeutic effects of probiotics.
Sulaimany S; Farahmandi K; Mafakheri A
Sci Rep; 2024 May; 14(1):11932. PubMed ID: 38789535
[TBL] [Abstract][Full Text] [Related]
14. Anti-tumor activities of probiotics in cervical cancer.
Jahanshahi M; Maleki Dana P; Badehnoosh B; Asemi Z; Hallajzadeh J; Mansournia MA; Yousefi B; Moazzami B; Chaichian S
J Ovarian Res; 2020 Jun; 13(1):68. PubMed ID: 32527332
[TBL] [Abstract][Full Text] [Related]
15. Deploying Lactulose as a Prebiotic to Reduce Complications of Chronic Liver Disease.
Holtz LR; DeBosch BJ
Gastroenterology; 2024 Mar; 166(3):534-535. PubMed ID: 38000683
[No Abstract] [Full Text] [Related]
16. [Pathological importance of dysbacteria of the large intestines].
ENTZEROTH R
Medizinische; 1952 Apr; 14():449-51. PubMed ID: 14956457
[No Abstract] [Full Text] [Related]
17. Correction: The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum.
Guo J; Li L; Cai Y; Kang Y
Cell Commun Signal; 2024 May; 22(1):294. PubMed ID: 38802831
[No Abstract] [Full Text] [Related]
18. Microbiota stability in healthy individuals after single-dose lactulose challenge-A randomized controlled study.
Wotzka SY; Kreuzer M; Maier L; Zünd M; Schlumberger M; Nguyen B; Fox M; Pohl D; Heinrich H; Rogler G; Biedermann L; Scharl M; Sunagawa S; Hardt WD; Misselwitz B
PLoS One; 2018; 13(10):e0206214. PubMed ID: 30359438
[TBL] [Abstract][Full Text] [Related]
19. The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured.
Palumbo P; Lombardi F; Cifone MG; Cinque B
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):199-206. PubMed ID: 30360752
[TBL] [Abstract][Full Text] [Related]
20. Immunological Tolerance and Function: Associations Between Intestinal Bacteria, Probiotics, Prebiotics, and Phages.
Vitetta L; Vitetta G; Hall S
Front Immunol; 2018; 9():2240. PubMed ID: 30356736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]